The protein hydrolysate, Primatone RL, is a cost-effective multiple growth promoter of mammalian cell culture in serum-containing and serum-free media and displays anti-apoptosis properties

The tryptic meat digest Primatone RL is a low-cost medium supplement of a complex nature which serves as a source of amino acids, oligopeptides, iron salts, some lipids and other trace low molecular weight substances. Its addition to mammalian and insect cell culture media significantly improves the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of immunological methods 1996-08, Vol.194 (2), p.191-199
1. Verfasser: Schlaeger, Ernst-Jürgen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 199
container_issue 2
container_start_page 191
container_title Journal of immunological methods
container_volume 194
creator Schlaeger, Ernst-Jürgen
description The tryptic meat digest Primatone RL is a low-cost medium supplement of a complex nature which serves as a source of amino acids, oligopeptides, iron salts, some lipids and other trace low molecular weight substances. Its addition to mammalian and insect cell culture media significantly improves the cell growth properties of many cell lines. In this work the growth promoting effects of Primatone RL are described in more detail using different mouse hybridomas, a mouse myeloma cell line, and human promyelocytic leukemia HL-60 cells. The positive effects on cell growth induced by Primatone were observed in the presence of serum but were even more pronounced in serum-free culture. In addition the adaptation time from high serum to low (1%) or serum-free growth in the presence of Primatone is also significantly reduced. Primatone RL, when added to HL and DHI medium, improves cell growth under low serum or serum-free conditions by increasing the maximum cell numbers and in particular the viability of the culture. The observed decrease in cell death (apoptosis) induction leads to a significant improvement in antibody (recombinant protein) production by increasing the volumetric yields during long-term batch culture. The so-called anti-apoptotic effects of Primatone RL for mouse hybridomas, which is concentration dependent, is not fully understood.
doi_str_mv 10.1016/0022-1759(96)00080-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78266945</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0022175996000804</els_id><sourcerecordid>78266945</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-adfa7cf2ea19ba13928ca96a1b67efaad0bd1d4c36995858ed21d7cc60e39d7d3</originalsourceid><addsrcrecordid>eNqFkd2KFDEQhRtR1nH1DRRyIaKwrUlPd35uBFn8gwFF1utQk1TvRLqTNkmvzMP5bqadZi71KiT11TmVOlX1lNHXjDL-htKmqZno1EvFX1FKJa3be9WGSdHUQtHufrU5Iw-rRyn9KBCjnF5UF1LwjolmU_2-OSCZYsjoPDkcbQzDMUHGK_I1uhFy8Ei-7a6ISwSICSnX2PdosrtDMs5DdtOA5DaGX_mwyIxFKJLQkxHGEQYHnhgcBmIKOkckxSRhnMfaBJ_BeedvCXi7PvYRiypaB38frUvTAMfi7LOrYQpTDqkMUnwmjNlhelw96GFI-GQ9L6vvH97fXH-qd18-fr5-t6tNy0SuwfYgTN8gMLUHtlWNNKA4sD0X2ANYurfMtmbLlepkJ9E2zApjOMWtssJuL6sXJ91i_XPGlPXo0vIx8BjmpIVsOFdt91-QdZIr2cgCtifQxJBSxF5Py77jUTOql3j1kp1estNquZR4dVvanq36874s6ty05lnqz9c6JANDH8Ebl87Ylkkl5CLz9oRhWdqdw6iTcehNWX0s4Wob3L_n-APnNsav</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15869828</pqid></control><display><type>article</type><title>The protein hydrolysate, Primatone RL, is a cost-effective multiple growth promoter of mammalian cell culture in serum-containing and serum-free media and displays anti-apoptosis properties</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Schlaeger, Ernst-Jürgen</creator><creatorcontrib>Schlaeger, Ernst-Jürgen</creatorcontrib><description>The tryptic meat digest Primatone RL is a low-cost medium supplement of a complex nature which serves as a source of amino acids, oligopeptides, iron salts, some lipids and other trace low molecular weight substances. Its addition to mammalian and insect cell culture media significantly improves the cell growth properties of many cell lines. In this work the growth promoting effects of Primatone RL are described in more detail using different mouse hybridomas, a mouse myeloma cell line, and human promyelocytic leukemia HL-60 cells. The positive effects on cell growth induced by Primatone were observed in the presence of serum but were even more pronounced in serum-free culture. In addition the adaptation time from high serum to low (1%) or serum-free growth in the presence of Primatone is also significantly reduced. Primatone RL, when added to HL and DHI medium, improves cell growth under low serum or serum-free conditions by increasing the maximum cell numbers and in particular the viability of the culture. The observed decrease in cell death (apoptosis) induction leads to a significant improvement in antibody (recombinant protein) production by increasing the volumetric yields during long-term batch culture. The so-called anti-apoptotic effects of Primatone RL for mouse hybridomas, which is concentration dependent, is not fully understood.</description><identifier>ISSN: 0022-1759</identifier><identifier>EISSN: 1872-7905</identifier><identifier>DOI: 10.1016/0022-1759(96)00080-4</identifier><identifier>PMID: 8765172</identifier><identifier>CODEN: JIMMBG</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Animal cells ; Animals ; Apoptosis ; Apoptosis - drug effects ; Biological and medical sciences ; Cell culture ; Cell cultures. Hybridization. Fusion ; Cell Division - drug effects ; Cells, Cultured ; Cost-Benefit Analysis ; Culture Media ; Culture Media, Serum-Free ; Cytological Techniques ; Fundamental and applied biological sciences. Psychology ; Growth Substances - economics ; Growth Substances - pharmacology ; HL-60 Cells - cytology ; HL-60 Cells - drug effects ; Humans ; Hybridoma ; Hybridomas - cytology ; Hybridomas - drug effects ; Mice ; Molecular and cellular biology ; Monoclonal antibody ; Multiple Myeloma - pathology ; Primatone RL ; Protein Hydrolysates - economics ; Protein Hydrolysates - pharmacology ; Serum-free ; Tumor Cells, Cultured - drug effects</subject><ispartof>Journal of immunological methods, 1996-08, Vol.194 (2), p.191-199</ispartof><rights>1996</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-adfa7cf2ea19ba13928ca96a1b67efaad0bd1d4c36995858ed21d7cc60e39d7d3</citedby><cites>FETCH-LOGICAL-c417t-adfa7cf2ea19ba13928ca96a1b67efaad0bd1d4c36995858ed21d7cc60e39d7d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0022175996000804$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3189784$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8765172$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schlaeger, Ernst-Jürgen</creatorcontrib><title>The protein hydrolysate, Primatone RL, is a cost-effective multiple growth promoter of mammalian cell culture in serum-containing and serum-free media and displays anti-apoptosis properties</title><title>Journal of immunological methods</title><addtitle>J Immunol Methods</addtitle><description>The tryptic meat digest Primatone RL is a low-cost medium supplement of a complex nature which serves as a source of amino acids, oligopeptides, iron salts, some lipids and other trace low molecular weight substances. Its addition to mammalian and insect cell culture media significantly improves the cell growth properties of many cell lines. In this work the growth promoting effects of Primatone RL are described in more detail using different mouse hybridomas, a mouse myeloma cell line, and human promyelocytic leukemia HL-60 cells. The positive effects on cell growth induced by Primatone were observed in the presence of serum but were even more pronounced in serum-free culture. In addition the adaptation time from high serum to low (1%) or serum-free growth in the presence of Primatone is also significantly reduced. Primatone RL, when added to HL and DHI medium, improves cell growth under low serum or serum-free conditions by increasing the maximum cell numbers and in particular the viability of the culture. The observed decrease in cell death (apoptosis) induction leads to a significant improvement in antibody (recombinant protein) production by increasing the volumetric yields during long-term batch culture. The so-called anti-apoptotic effects of Primatone RL for mouse hybridomas, which is concentration dependent, is not fully understood.</description><subject>Animal cells</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Biological and medical sciences</subject><subject>Cell culture</subject><subject>Cell cultures. Hybridization. Fusion</subject><subject>Cell Division - drug effects</subject><subject>Cells, Cultured</subject><subject>Cost-Benefit Analysis</subject><subject>Culture Media</subject><subject>Culture Media, Serum-Free</subject><subject>Cytological Techniques</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Growth Substances - economics</subject><subject>Growth Substances - pharmacology</subject><subject>HL-60 Cells - cytology</subject><subject>HL-60 Cells - drug effects</subject><subject>Humans</subject><subject>Hybridoma</subject><subject>Hybridomas - cytology</subject><subject>Hybridomas - drug effects</subject><subject>Mice</subject><subject>Molecular and cellular biology</subject><subject>Monoclonal antibody</subject><subject>Multiple Myeloma - pathology</subject><subject>Primatone RL</subject><subject>Protein Hydrolysates - economics</subject><subject>Protein Hydrolysates - pharmacology</subject><subject>Serum-free</subject><subject>Tumor Cells, Cultured - drug effects</subject><issn>0022-1759</issn><issn>1872-7905</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkd2KFDEQhRtR1nH1DRRyIaKwrUlPd35uBFn8gwFF1utQk1TvRLqTNkmvzMP5bqadZi71KiT11TmVOlX1lNHXjDL-htKmqZno1EvFX1FKJa3be9WGSdHUQtHufrU5Iw-rRyn9KBCjnF5UF1LwjolmU_2-OSCZYsjoPDkcbQzDMUHGK_I1uhFy8Ei-7a6ISwSICSnX2PdosrtDMs5DdtOA5DaGX_mwyIxFKJLQkxHGEQYHnhgcBmIKOkckxSRhnMfaBJ_BeedvCXi7PvYRiypaB38frUvTAMfi7LOrYQpTDqkMUnwmjNlhelw96GFI-GQ9L6vvH97fXH-qd18-fr5-t6tNy0SuwfYgTN8gMLUHtlWNNKA4sD0X2ANYurfMtmbLlepkJ9E2zApjOMWtssJuL6sXJ91i_XPGlPXo0vIx8BjmpIVsOFdt91-QdZIr2cgCtifQxJBSxF5Py77jUTOql3j1kp1estNquZR4dVvanq36874s6ty05lnqz9c6JANDH8Ebl87Ylkkl5CLz9oRhWdqdw6iTcehNWX0s4Wob3L_n-APnNsav</recordid><startdate>19960814</startdate><enddate>19960814</enddate><creator>Schlaeger, Ernst-Jürgen</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7T5</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19960814</creationdate><title>The protein hydrolysate, Primatone RL, is a cost-effective multiple growth promoter of mammalian cell culture in serum-containing and serum-free media and displays anti-apoptosis properties</title><author>Schlaeger, Ernst-Jürgen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-adfa7cf2ea19ba13928ca96a1b67efaad0bd1d4c36995858ed21d7cc60e39d7d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Animal cells</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Biological and medical sciences</topic><topic>Cell culture</topic><topic>Cell cultures. Hybridization. Fusion</topic><topic>Cell Division - drug effects</topic><topic>Cells, Cultured</topic><topic>Cost-Benefit Analysis</topic><topic>Culture Media</topic><topic>Culture Media, Serum-Free</topic><topic>Cytological Techniques</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Growth Substances - economics</topic><topic>Growth Substances - pharmacology</topic><topic>HL-60 Cells - cytology</topic><topic>HL-60 Cells - drug effects</topic><topic>Humans</topic><topic>Hybridoma</topic><topic>Hybridomas - cytology</topic><topic>Hybridomas - drug effects</topic><topic>Mice</topic><topic>Molecular and cellular biology</topic><topic>Monoclonal antibody</topic><topic>Multiple Myeloma - pathology</topic><topic>Primatone RL</topic><topic>Protein Hydrolysates - economics</topic><topic>Protein Hydrolysates - pharmacology</topic><topic>Serum-free</topic><topic>Tumor Cells, Cultured - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schlaeger, Ernst-Jürgen</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of immunological methods</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schlaeger, Ernst-Jürgen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The protein hydrolysate, Primatone RL, is a cost-effective multiple growth promoter of mammalian cell culture in serum-containing and serum-free media and displays anti-apoptosis properties</atitle><jtitle>Journal of immunological methods</jtitle><addtitle>J Immunol Methods</addtitle><date>1996-08-14</date><risdate>1996</risdate><volume>194</volume><issue>2</issue><spage>191</spage><epage>199</epage><pages>191-199</pages><issn>0022-1759</issn><eissn>1872-7905</eissn><coden>JIMMBG</coden><abstract>The tryptic meat digest Primatone RL is a low-cost medium supplement of a complex nature which serves as a source of amino acids, oligopeptides, iron salts, some lipids and other trace low molecular weight substances. Its addition to mammalian and insect cell culture media significantly improves the cell growth properties of many cell lines. In this work the growth promoting effects of Primatone RL are described in more detail using different mouse hybridomas, a mouse myeloma cell line, and human promyelocytic leukemia HL-60 cells. The positive effects on cell growth induced by Primatone were observed in the presence of serum but were even more pronounced in serum-free culture. In addition the adaptation time from high serum to low (1%) or serum-free growth in the presence of Primatone is also significantly reduced. Primatone RL, when added to HL and DHI medium, improves cell growth under low serum or serum-free conditions by increasing the maximum cell numbers and in particular the viability of the culture. The observed decrease in cell death (apoptosis) induction leads to a significant improvement in antibody (recombinant protein) production by increasing the volumetric yields during long-term batch culture. The so-called anti-apoptotic effects of Primatone RL for mouse hybridomas, which is concentration dependent, is not fully understood.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>8765172</pmid><doi>10.1016/0022-1759(96)00080-4</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-1759
ispartof Journal of immunological methods, 1996-08, Vol.194 (2), p.191-199
issn 0022-1759
1872-7905
language eng
recordid cdi_proquest_miscellaneous_78266945
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animal cells
Animals
Apoptosis
Apoptosis - drug effects
Biological and medical sciences
Cell culture
Cell cultures. Hybridization. Fusion
Cell Division - drug effects
Cells, Cultured
Cost-Benefit Analysis
Culture Media
Culture Media, Serum-Free
Cytological Techniques
Fundamental and applied biological sciences. Psychology
Growth Substances - economics
Growth Substances - pharmacology
HL-60 Cells - cytology
HL-60 Cells - drug effects
Humans
Hybridoma
Hybridomas - cytology
Hybridomas - drug effects
Mice
Molecular and cellular biology
Monoclonal antibody
Multiple Myeloma - pathology
Primatone RL
Protein Hydrolysates - economics
Protein Hydrolysates - pharmacology
Serum-free
Tumor Cells, Cultured - drug effects
title The protein hydrolysate, Primatone RL, is a cost-effective multiple growth promoter of mammalian cell culture in serum-containing and serum-free media and displays anti-apoptosis properties
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T11%3A43%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20protein%20hydrolysate,%20Primatone%20RL,%20is%20a%20cost-effective%20multiple%20growth%20promoter%20of%20mammalian%20cell%20culture%20in%20serum-containing%20and%20serum-free%20media%20and%20displays%20anti-apoptosis%20properties&rft.jtitle=Journal%20of%20immunological%20methods&rft.au=Schlaeger,%20Ernst-J%C3%BCrgen&rft.date=1996-08-14&rft.volume=194&rft.issue=2&rft.spage=191&rft.epage=199&rft.pages=191-199&rft.issn=0022-1759&rft.eissn=1872-7905&rft.coden=JIMMBG&rft_id=info:doi/10.1016/0022-1759(96)00080-4&rft_dat=%3Cproquest_cross%3E78266945%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15869828&rft_id=info:pmid/8765172&rft_els_id=0022175996000804&rfr_iscdi=true